Ginès P - Search Results

1

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.

Ma AT, Solé C, Juanola A, Escudé L, Napoleone L, Avitabile E, Pérez-Guasch M, Carol M, Pompili E, Gratacós-Ginés J, Soria A, Rubio AB, Cervera M, Moreta MJ, Morales-Ruiz M, Solà E, Poch E, Fabrellas N, Graupera I, Pose E, Ginès P. Ma AT, et al. Among authors: gines p. J Hepatol. 2024 Sep;81(3):441-450. doi: 10.1016/j.jhep.2024.03.006. Epub 2024 Mar 11. J Hepatol. 2024. PMID: 38479614 Free article.

2

Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis.

Arroyo V, Ginés P. Arroyo V, et al. Among authors: gines p. J Hepatol. 1990 Sep;11(2):142-4. doi: 10.1016/0168-8278(90)90104-y. J Hepatol. 1990. PMID: 2254624 Review. No abstract available.

3

Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.

Solà R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, Ledesma S, Ginès P, Jiménez W, Arroyo V. Solà R, et al. Among authors: gines p. J Hepatol. 1994 Feb;20(2):282-8. doi: 10.1016/s0168-8278(05)80070-4. J Hepatol. 1994. PMID: 7516361 Clinical Trial.

4

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.

Ginès A, Salmerón JM, Ginès P, Arroyo V, Jiménez W, Rivera F, Rodés J. Ginès A, et al. Among authors: gines p. J Hepatol. 1993 Feb;17(2):220-6. doi: 10.1016/s0168-8278(05)80042-x. J Hepatol. 1993. PMID: 8445236

5

Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.

Ginès P, Jiménez W. Ginès P, et al. J Hepatol. 1996 Apr;24(4):506-12. doi: 10.1016/s0168-8278(96)80174-7. J Hepatol. 1996. PMID: 8738740 Review.

6

Urinary endothelin-like immunoreactivity in patients with cirrhosis.

Saló J, Fernández-Esparrach G, Ginès P, Ginès A, Guevara M, Sort P, Jiménez W, Arroyo V, Rivera F, Rodés J. Saló J, et al. Among authors: gines p, gines a. J Hepatol. 1997 Nov;27(5):810-6. doi: 10.1016/s0168-8278(97)80317-0. J Hepatol. 1997. PMID: 9382967

7

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J. Uriz J, et al. Among authors: gines p. J Hepatol. 2000 Jul;33(1):43-8. doi: 10.1016/s0168-8278(00)80158-0. J Hepatol. 2000. PMID: 10905585 Clinical Trial.

8

A prognostic model for predicting survival in cirrhosis with ascites.

Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J. Fernández-Esparrach G, et al. Among authors: gines p. J Hepatol. 2001 Jan;34(1):46-52. doi: 10.1016/s0168-8278(00)00011-8. J Hepatol. 2001. PMID: 11211907

9

Increased plasma levels of neuropeptide Y in hepatorenal syndrome.

Uriz J, Ginès P, Ortega R, Jiménez W, Cárdenas A, Calahorra B, Sort P, Fernández J, Bataller R, Arroyo V, Rivera F, Rodés J. Uriz J, et al. Among authors: gines p. J Hepatol. 2002 Mar;36(3):349-55. doi: 10.1016/s0168-8278(01)00286-0. J Hepatol. 2002. PMID: 11867178

10

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Ortega R, Ginès P, Uriz J, Cárdenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jiménez W, Arroyo V, Rodés J. Ortega R, et al. Among authors: gines p. Hepatology. 2002 Oct;36(4 Pt 1):941-8. doi: 10.1053/jhep.2002.35819. Hepatology. 2002. PMID: 12297842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters